S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

KALA KALA BIO Inc

5.52

0.00 (0.00%)

Pre Market

Last Updated: 04:38:39

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

KALA BIO (NASDAQ:KALA)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more KALA BIO Charts.

KALA BIO (NASDAQ:KALA)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more KALA BIO Charts.

KALA BIO Inc News

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 6 September 2024 (3 weeks ago) • Edgar (US Regulatory)

KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
Thursday 8 August 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 6 August 2024 (2 months ago) • Edgar (US Regulatory)

KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Tuesday 6 August 2024 (2 months ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Wednesday 31 July 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Wednesday 31 July 2024 (2 months ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Thursday 25 July 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 17 July 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 16 July 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Monday 8 July 2024 (3 months ago) • Edgar (US Regulatory)

KALA BIO Announces $12,500,000 Private Placement
Thursday 27 June 2024 (3 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 12 June 2024 (3 months ago) • Edgar (US Regulatory)

More KALA BIO Inc News Articles

ProText Mobility (PK)

TransCode Therapeutics

AMC Entertainment

NioCorp Developments

Lightwave Logic

Movement Industries (PK)

GNCC Capital (CE)

Kraig Biocraft Laborator... (QB)

Marketing Worldwide (PK)

Accredited Solutions (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions